TissueLabs

TissueLabs is a biotechnology company that provides a comprehensive biofabrication platform designed to create human-like tissues and organs in laboratory settings. The company has developed a suite of specialized 3D bioprinters, such as the TissueStart, TissueRay, and TissuePro models, which are engineered for precision and ease of use. Complementing this hardware is their proprietary line of MatriXpec tissue-specific biomaterials, which are produced through a scalable decellularization process to replicate the extracellular matrix of 15 different human tissue types. By integrating these advanced bioprinting systems with biomaterials that provide essential structural and biochemical cues, the platform allows researchers to produce complex, functional 3D tissue architectures.

The platform serves researchers across academia, pharmaceutical companies, and biotechnology startups, addressing critical needs in fields such as drug discovery, disease modeling, personalized medicine, and regenerative medicine. By offering tools that make biofabrication more accessible and cost-effective, TissueLabs aims to accelerate the transition from laboratory experimentation to clinical application. Their technologies enable the creation of physiologically relevant models, which are used to improve the efficiency and reliability of pharmacological testing and tissue engineering studies. The company, founded in 2019 and headquartered in Switzerland, continues to advance its core vision of democratizing biofabrication to improve patient outcomes and move closer to the long-term goal of developing bioartificial organs for transplantation.